Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading

被引:23
|
作者
Azorin, Jean-Michel [1 ]
Belzeaux, Raoul [1 ]
Adida, Marc [1 ]
机构
[1] St Marguerite Hosp, Dept Psychiat, F-13274 Marseille 9, France
关键词
History; Negative symptoms; Pathophysiology; Psychopathology; Schizophrenia; Treatment; DOUBLE-BLIND; RANDOMIZED-TRIAL; FEARFUL FACES; THERAPY; ANHEDONIA; AUGMENTATION; METAANALYSIS; ACTIVATION; CLOZAPINE; RESPONSES;
D O I
10.1111/cns.12292
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This review traces the history of negative symptom profiles in neuropsychiatry from their earliest emergence in the 19th century to the current psychiatric concepts and therapeutic approaches. Recent investigations performing exploratory and confirmatory factor analysis have suggested that negative symptoms are multidimensional, including evidence for at least two distinct negative symptom subdomains: diminished expression and amotivation. Preliminary studies have demonstrated the clinical validity of this distinction. Several potential pathophysiological validating factors based on brain imaging analysis of emotional experiences and expressions in individuals with schizophrenia are examined. Finally, the potential of different treatment strategies, including medications and various psychotherapeutic techniques, to most favorably treat each of these subdomains is discussed.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 50 条
  • [41] Thirty-Year Experience with Bilateral Internal Thoracic Artery Grafting: Where Have We Been and Where Are We Going?
    Kurlansky, Paul
    WORLD JOURNAL OF SURGERY, 2010, 34 (04) : 646 - 651
  • [42] Dental occlusion, body posture and temporomandibular disorders: where we are now and where we are heading for
    Manfredini, D.
    Castroflorio, T.
    Perinetti, G.
    Guarda-Nardini, L.
    JOURNAL OF ORAL REHABILITATION, 2012, 39 (06) : 463 - 471
  • [43] Pediatric surgical oncology: A brief overview of where we have been and the challenges we face
    von Allmen, Daniel
    SEMINARS IN PEDIATRIC SURGERY, 2019, 28 (06)
  • [44] Remediation of Visual Processing Impairments in Schizophrenia: Where We Are and Where We Need to Be
    Demmin, Docia L.
    Fradkin, Samantha, I
    Silverstein, Steven M.
    CURRENT BEHAVIORAL NEUROSCIENCE REPORTS, 2019, 6 (02) : 13 - 20
  • [45] Pain perception in people diagnosed with schizophrenia: where we are and where we are going
    Sakson-Obada, O.
    PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES, 2017, 9 (04): : 358 - 366
  • [46] Remediation of Visual Processing Impairments in Schizophrenia: Where We Are and Where We Need to Be
    Docia L. Demmin
    Samantha I. Fradkin
    Steven M. Silverstein
    Current Behavioral Neuroscience Reports, 2019, 6 : 13 - 20
  • [47] Stroke research at the crossroads - where are we heading?
    Roth, Stefan
    Liesz, Arthur
    SWISS MEDICAL WEEKLY, 2016, 146 : w14329
  • [48] Drugs and public health: where are we heading to?
    Elena Medina-Mora, Maria
    Real, Tania
    Villatoro, Jorge
    Natera, Guillermina
    SALUD PUBLICA DE MEXICO, 2013, 55 (01): : 67 - 73
  • [49] Genomic substrates of neurophysiological endophenotypes: Where we've been and where we're going
    Braff, David L.
    PSYCHOPHYSIOLOGY, 2014, 51 (12) : 1323 - 1324
  • [50] Translational Stroke Research: Where Have We Been and Where are We Going? Interviewing Dr. Marc Fisher (editor of Stroke)
    Saposnik, Gustavo
    Fisher, Marc
    Schweizer, Tom A.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2015, 42 (01) : 2 - 6